MEDIFAST INC
MEDNYSEConsumer Staples · Miscellaneous Food Preparations & Kindred Products · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $385.8M | $602.5M | $1.07B | $1.60B | $1.53B | $934.8M |
| Operating income | −$14.2M | $2.9M | $126.4M | $184.8M | $216.2M | $134.2M |
| Net income | −$18.7M | $2.1M | $99.4M | $143.6M | $164.0M | $102.9M |
| Total assets | $248.0M | $284.2M | $309.9M | $316.2M | $398.3M | $276.1M |
| Total liabilities | $49.1M | $74.1M | $108.4M | $161.2M | $195.9M | $118.8M |
| Equity | $198.9M | $210.1M | $201.5M | $155.0M | $202.5M | $157.2M |
| EPS (diluted) | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 | $8.68 |
| Shares out. | 10.9M | 10.9M | 10.8M | 11.5M | 11.8M | 11.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −3.7%
- Net margin
- −4.8%
- Return on equity
- −9.4%
- Return on assets
- −7.5%
- Return on capital (ROCE)
- −6.9%
- Liabilities / assets
- 19.8%
- Debt / equity
- 0.25×
- Book value / share
- $18.19
- Revenue growth (YoY)
- −36.0%
- Net income growth (YoY)
- −993.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 10.15safe
- Accruals / assets
- −10.3%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 16, 2011
- NT 10-Kmissed a reporting deadline ↗Mar 16, 2010
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Citadel Securities Gp LlcPassive (13G)May 15, 2026
- Renaissance Technologies LlcPassive (13G)May 14, 2026
- Charles Schwab Investment Management IncPassive (13G)May 14, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Steamboat Capital Partners, LlcActivist (13D)Mar 20, 2026
- Susquehanna Securities, LlcPassive (13G)Feb 13, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.2M | 9.3 | +7.6% |
| Apr 30, 2026 | 2.0M | 13.2 | -6.1% |
| Apr 15, 2026 | 2.2M | 9.3 | +5.3% |
| Mar 31, 2026 | 2.1M | 6.8 | +0.9% |
| Mar 13, 2026 | 2.0M | 7.5 | +0.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeJun 1, 2026
- Director / officer change · Shareholder vote · Regulation FD disclosureMay 26, 2026
- Results of operationsMay 4, 2026
- Entered a material agreement · Director / officer change · Regulation FD disclosureMar 20, 2026
- Results of operationsFeb 17, 2026
- Director / officer changeJan 5, 2026
- Results of operationsNov 3, 2025
- Results of operationsAug 4, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KJun 1, 2026
- 4FORM 4May 28, 2026
- 4FORM 4May 28, 2026
- 4FORM 4May 28, 2026
- 4FORM 4May 28, 2026
- 4FORM 4May 28, 2026
- 4FORM 4May 28, 2026
- 3FORM 3May 28, 2026
- 3FORM 3May 28, 2026
- 8-KMay 26, 2026
- SCHEDULE 13GMay 15, 2026
- SCHEDULE 13G/AMay 14, 2026
- SCHEDULE 13G/AMay 14, 2026
- 4FORM 4May 12, 2026
- 10-QMay 4, 2026